1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase III Study of Toripalimab(JS001) Combined With Lenvatinib for Advanced HCCAdvanced Hepatocellular Carcinoma (HCC)Active, not recruitingPhase 32026-07-06NCT04523493